Merit Medical Announces Resignation of President, Joseph Wright
| 65339KCH1 | 100.19 0.29 0.29% |
About 55% of 65339KCH1's investor base is interested to short. The analysis of the overall prospects from investing in NEE 4625 15 JUL 27 suggests that many traders are, at the present time, impartial. The current market sentiment, together with 65339KCH1's historical and current headlines, can help investors time the market. In addition, many technical investors use NEE 4625 15 bond news signals to limit their universe of possible portfolio assets.
65339KCH1 |
SOUTH JORDAN, Utah, Dec. 16, 2024 -- Merit Medical Systems, Inc. , a global leader of healthcare te
Read at gurufocus.com
 |
NEE 4625 15 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 65339KCH1 bond to make a market-neutral strategy. Peer analysis of 65339KCH1 could also be used in its relative valuation, which is a method of valuing 65339KCH1 by comparing valuation metrics with similar companies.
Peers
65339KCH1 Related Equities
| SMMT | Summit Therapeutics | 3.95 | ||||
| NEOG | Neogen | 1.96 | ||||
| KTB | Kontoor Brands | 0.24 | ||||
| SYRE | Spyre Therapeutics | 0.29 | ||||
| RDNT | RadNet | 0.44 | ||||
| TLF | Tandy Leather | 0.64 | ||||
| LEVI | Levi Strauss | 0.95 | ||||
| ALVO | Alvotech | 1.50 |
Other Information on Investing in 65339KCH1 Bond
65339KCH1 financial ratios help investors to determine whether 65339KCH1 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 65339KCH1 with respect to the benefits of owning 65339KCH1 security.